Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Strong Buy
Price to Earnings Rating
Neutral
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Sell
C
eFFECTOR Therapeutics, Inc. Warrant (EFTRW)
Pharmaceutical Preparations
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).
142 NORTH CEDROS AVENUE, SUITE B
SOLANA BEACH, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
08/26/2021
Market Cap
9,408
Shares Outstanding
62,500,000
Weighted SO
N/A
Total Employees
N/A
Upcoming Earnings
N/A
Similar Tickers
Beta
0.6070
Last Div
0.0000
Range
0.002-0.002
Chg
-0.0033
Avg Vol
N/A
Mkt Cap
9408
Exch
NASDAQ
Country
US
Phone
858 925 8215
DCF Diff
4.2297
DCF
-2.0897
Div Yield
0.0000
P/S
1.3939
EV Multiple
-0.1205
P/FV
0.2369
Div Yield %
0.0000
P/E
-0.0057
PEG
0.0001
Payout
0.0000
Current Ratio
1.0266
Quick Ratio
1.0266
Cash Ratio
0.6065
DSO
38.3025
DIO
0.0000
Op Cycle
38.3025
DPO
5632.8378
CCC
-5594.5354
Gross Margin
0.3148
Op Margin
-201.8704
Pretax Margin
-213.7654
Net Margin
-213.7654
Eff Tax Rate
-0.0065
ROA
-1.2764
ROE
21.7833
ROCE
-20.9366
NI/EBT
1.0000
EBT/EBIT
1.0589
EBIT/Rev
-201.8704
Debt Ratio
0.7058
D/E
23.1536
LT Debt/Cap
0.1779
Total Debt/Cap
0.9586
Int Coverage
-10.9778
CF/Debt
-1.5245
Equity Multi
32.8065
Rec Turnover
9.5294
Pay Turnover
0.0648
Inv Turnover
0.0000
FA Turnover
0.3904
Asset Turnover
0.0060
OCF/Share
-7.1519
FCF/Share
-7.1725
Cash/Share
6.2189
OCF/Sales
-180.1914
FCF/OCF
1.0029
CF Coverage
-1.5245
ST Coverage
-1.5389
CapEx Coverage
-347.5119
Div&CapEx Cov
-347.5119
P/BV
0.2369
P/B
0.2369
P/S
1.3939
P/E
-0.0057
P/FCF
-0.0077
P/OCF
-0.0067
P/CF
-0.0067
PEG
0.0001
P/S
1.3939
EV Multiple
-0.1205
P/FV
0.2369
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2021 | 2022 | 2023 | 2024 | 2024 | 1970 | 1970 | |
---|---|---|---|---|---|---|---|
Revenue | 42.00K | ▲ 1.43M | ▼ 675.00K | ▼ 162.00K | ▼ 0.00 | ||
Cost Of Revenue | 4.60M | ▼ 4.00K | ▲ 27.00K | ▲ 30.00K | ▼ 28.00K | ▼ | |
Gross Profit | -4.56M | ▲ 1.43M | ▼ 648.00K | ▼ 132.00K | ▼ -28.00K | ▼ | |
Gross Profit Ratio | -100.00 | ▲ 1.00 | ▼ 0.96 | ▼ 0.81 | ▼ 0.00 | ▼ | |
Research And Development Expenses | 4.60M | ▲ 6.39M | ▲ 6.65M | ▼ 6.04M | ▼ 5.28M | ▼ | |
General And Administrative Expenses | 1.06M | ▲ 6.32M | ▼ 2.75M | ▼ 2.52M | ▲ 3.09M | ▼ | |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
Selling General And Administrative Expenses | 1.06M | ▲ 6.32M | ▼ 2.75M | ▼ 2.52M | ▲ 3.09M | ▼ | |
Other Expenses | 77.00K | ▼ -311.00K | ▼ -674.00K | ▲ 3.00K | ▼ -12.00K | ▼ | |
Operating Expenses | 5.66M | ▲ 12.40M | ▼ 8.72M | ▼ 8.57M | ▼ 8.37M | ▼ | |
Cost And Expenses | 5.66M | ▲ 12.40M | ▼ 8.72M | ▼ 8.60M | ▼ 8.40M | ▼ | |
Interest Income | 2.00K | ▲ 4.00K | ▲ 209.00K | ▲ 223.00K | ▲ 323.00K | ▼ | |
Interest Expense | 314.00K | ▲ 490.00K | ▲ 697.00K | ▲ 758.00K | ▼ 749.00K | ▼ | |
Depreciation And Amortization | 33.00K | ▼ 4.00K | ▲ 27.00K | ▲ 30.00K | ▼ 28.00K | ▼ | |
Ebitda | -5.51M | ▼ -12.40M | ▲ -8.72M | ▲ -8.57M | ▲ -8.37M | ▼ | |
Ebitda Ratio | -100.00 | ▲ -8.67 | ▼ -12.92 | ▼ -52.88 | ▲ 0.00 | ▼ | |
Operating Income | -5.62M | ▲ 20.03M | ▼ -8.72M | ▲ -8.60M | ▲ -8.40M | ▼ | |
Operating Income Ratio | -133.79 | ▲ 14.01 | ▼ -12.92 | ▼ -53.07 | ▲ 0.00 | ▼ | |
Total Other Income Expenses Net | 77.00K | ▼ -980.00K | ▲ -538.00K | ▲ -532.00K | ▲ -438.00K | ▼ | |
Income Before Tax | -5.85M | ▲ 19.05M | ▼ -9.26M | ▲ -9.13M | ▲ -8.83M | ▼ | |
Income Before Tax Ratio | -100.00 | ▲ 13.32 | ▼ -13.72 | ▼ -56.35 | ▲ 0.00 | ▼ | |
Income Tax Expense | -5.07M | ▼ -32.44M | ▲ -28.00K | ▼ -688.00K | ▲ -15.28K | ▼ | |
Net Income | -397.00K | ▲ 19.05M | ▼ -9.26M | ▲ -9.13M | ▲ -8.83M | ▼ | |
Net Income Ratio | -9.45 | ▲ 13.32 | ▼ -13.72 | ▼ -56.35 | ▲ 0.00 | ▼ | |
Eps | -0.66 | ▲ 11.79 | ▼ -5.57 | ▲ -3.42 | ▲ -2.16 | ▼ | |
Eps Diluted | -0.66 | ▲ 11.79 | ▼ -5.57 | ▲ -3.42 | ▲ -2.16 | ▼ | |
Weighted Average Shs Out | 598.56K | ▲ 1.62M | ▲ 1.66M | ▲ 2.67M | ▲ 4.08M | ▼ | |
Weighted Average Shs Out Dil | 598.56K | ▲ 1.62M | ▲ 1.66M | ▲ 2.67M | ▲ 4.08M | ▼ |